Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

被引：3

作者：

Hsieh, Meng-Hsuan ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Bair, Ming-Jong ^{[14
]}

Tsai, Pei-Chien ^{[2
,3
]}

Tseng, Kuo-Chih ^{[32
]}

Lo, Ching-Chu ^{[19
]}

Chen, Chi-Yi ^{[20
]}

Kuo, Hsing-Tao ^{[23
]}

Hung, Chao-Hung ^{[9
,10
]}

Lai, Hsueh-Chou ^{[18
]}

Peng, Cheng-Yuan ^{[18
]}

Wang, Jing-Houng ^{[21
]}

Chen, Jyh-Jou ^{[33
]}

Lee, Pei-Lun ^{[33
]}

Chien, Rong-Nan ^{[24
]}

Yang, Chi-Chieh ^{[16
]}

Lo, Gin-Ho ^{[11
,12
]}

Kao, Jia-Horng ^{[25
,26
]}

Liu, Chun-Jen ^{[25
,26
]}

Liu, Chen-Hua ^{[25
,26
]}

Yan, Sheng-Lei ^{[17
]}

Lin, Chun-Yen ^{[24
]}

Su, Wei-Wen ^{[15
]}

Chu, Cheng-Hsin ^{[27
]}

Chen, Chih-Jen ^{[27
]}

Tung, Shui-Yi ^{[9
,10
]}

Tai, Chi-Ming ^{[11
,12
]}

Lin, Chih-Wen ^{[11
,12
]}

Cheng, Pin-Nan ^{[22
]}

Chiu, Yen-Cheng ^{[22
]}

Wang, Chia-Chi ^{[30
,31
]}

Cheng, Jin-Shiung ^{[13
]}

Tsai, Wei-Lun ^{[13
]}

Lin, Han-Chieh ^{[28
]}

Huang, Yi-Hsiang ^{[28
,29
]}

Yeh, Ming-Lun ^{[2
,3
,4
,5
,6
,7
]}

Huang, Chung-Feng ^{[2
,3
,4
,5
,6
,7
]}

Huang, Jee-Fu ^{[2
,3
,4
,5
,6
,7
]}

Dai, Chia-Yen ^{[2
,3
,4
,5
,6
,7
]}

Yu, Ming-Lung ^{[2
,3
,4
,5
,6
,7
]}

Chuang, Wan-Long ^{[2
,3
,4
,5
,6
,7
]}

机构：

[1] Kaohsiung Med Univ Hosp, Hlth Management Ctr, Dept Occupat & Environm Med, Kaohsiung, Taiwan

[2] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan

[3] Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan

[4] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan

[5] Kaohsiung Med Univ, Hepatitis Res Ctr, Coll Med, Kaohsiung, Taiwan

[6] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan

[7] Kaohsiung Med Univ, Ctr Liquid Biopsy & Cohort Res, Kaohsiung, Taiwan

[8] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan

[9] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan

[10] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan

[11] I Shou Univ, E Da Hosp, Dept Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan

[12] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan

[13] Kaohsiung Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Kaohsiung, Taiwan

[14] Taitung Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taitung, Taiwan

[15] Changhua Christian Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan

[16] Show Chwan Mem Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan

[17] Chang Bing Show Chwan Mem Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan

[18] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan

[19] St Martin Porres Hosp Daya, Dept Internal Med, Daya, Taiwan

[20] Chiayi Christian Hosp, Dept Internal Med, Chiayi, Taiwan

[21] ChiaYi Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Chiayi, Taiwan

[22] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med,Coll Med, Tainan, Taiwan

[23] Chi Mei Med Ctr, Div Hepatogastroenterol, Dept Internal Med, Tainan, Taiwan

[24] Chang Gung Mem Hosp, Div Hepatol, Dept Gastroenterol & Hepatol, Linkou Med Ctr, Keelung, Taiwan

[25] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan

[26] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan

[27] MacKay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan

[28] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan

[29] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan

[30] Buddhist Tzuchi Med Fdn, Div Gastroenterol, Taipei Tzuchi Hosp, Dept Internal Med, New Taipei, Taiwan

[31] Tzu Chi Univ, Sch Med, Hualien, Taiwan

[32] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Gastroenterol, Chiayi, Taiwan

[33] Chi Mei Med Ctr, Div Gastroenterol & Hepatol, Tainan, Taiwan

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷 / 08期

关键词：

chronic kidney disease; end‐ stage renal disease; hepatitis C virus; interferon; VIRUS-INFECTION; GLUCOSE ABNORMALITIES; VIRAL-HEPATITIS; FIBROSIS; OUTCOMES; ASSOCIATION; NATIONWIDE; GENOTYPE; COHORT; AREA;

D O I：

10.1111/jgh.15469

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background and Aim Chronic hepatitis C virus (HCV) infection is associated with impaired renal function. The aim of this study is to explore the risk of and factors associated with end-stage renal diseases (ESRD) under maintenance dialysis among HCV patients after anti-HCV therapy. Methods A total of 12 696 HCV-infected patients with interferon-based therapy, including 9679 (76.2%) achieving sustained virological response (SVR), were enrolled from 23 hospitals in Taiwan. Results During a mean follow-up period of 5.3 years (67 554 person-years), the annual incidence of 4.1/10 000 person-years, 4.0/10 000 and 4.7/10 000 person-years among SVR patients and non-SVR patients, respectively. History of diabetes and baseline estimated glomerular filtration rate < 60 mL/min/m(2), instead of SVR, were the significant risk factors for developing ESRD with maintenance dialysis after anti-HCV therapy (adjusted hazard ratio 7.75 and 9.78). Conclusion Diabetes and baseline impaired renal function were strongly associated with progression to ESRD with maintenance dialysis among chronic HCV-infected patients after antiviral therapy.

引用

页码：2247 / 2254

页数：8

共 50 条

[21] Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients
Kshirsagar, Abhijit, V
Li, Xiaojuan
ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 292 - 297
[22] The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease
Behera, Manas K.
Majji, Prabir
Behera, Sanatan
Pani, Manoj
Mohapatro, Arupam
Patra, Umesh C.
Jena, Susanta K.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (04)
[23] Ischemic Stroke among the Patients with End-Stage Renal Disease Who Were Undergoing Maintenance Dialysis
Jung, San
Kwon, Seok-Beom
Hwang, Sung-Hee
Noh, Jung Woo
Lee, Young-Ki
YONSEI MEDICAL JOURNAL, 2012, 53 (05) : 894 - 900
[24] Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis
Taneja, Sunil
Duseja, Ajay
Mehta, Manu
De, Arka
Verma, Nipun
Premkumar, Madhumita
Dhiman, Radha K.
Singh, Virendra
Singh, Mini P.
Ratho, Radha K.
Ramachandran, Raja
Kumar, Vivek
Kohli, Harbir S.
LIVER INTERNATIONAL, 2021, 41 (04) : 705 - 709
[25] Impact of sarcopenia on long-term survival after cardiac surgery for end-stage renal disease patients
Ikushima, Eigo
Yasutsune, Toru
Kishigami, Takehiro
Takigawa, Tomoya
Jinzai, Yuki
Kado, Yuichiro
Nishimura, Yosuke
ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2023, 31 (08) : 699 - 705
[26] Long-term prognosis in patients with end-stage renal disease after coronary artery bypass grafting
Pang, Philip Y. K.
Teow, Christopher K. J.
Huang, Ming Jie
Naik, Madhava J.
Lim, See Lim
Chao, Victor T. T.
Tan, Teing Ee
Chua, Yeow Leng
Sin, Yoong Kong
JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6722 - 6730
[27] Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience
Tatar, Bengu
Kose, Sukran
Ergun, Nadide Colak
Turken, Melda
Onlen, Yusuf
Yilmaz, Yusuf
Akhan, Sila
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (12): : 1470 - 1475
[28] Telomere Attrition and Elongation after Chronic Dialysis Initiation in Patients with End-Stage Renal Disease
Kato, Sawako
Shiels, Paul G.
McGuinness, Dagmara
Lindholm, Bengt
Stenvinkel, Peter
Nordfors, Louise
Qureshi, Abdul Rashid
Yuzawa, Yukio
Matsuo, Seiichi
Maruyama, Shoichi
BLOOD PURIFICATION, 2016, 41 (1-3) : 25 - 33
[29] Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C
Arase, Yasuji
Ikeda, Kenji
Suzuki, Fumitaka
Suzuki, Yoshiyuki
Saitoh, Satoshi
Kobayashi, Masahiro
Akuta, Norio
Someya, Takashi
Koyama, Rikako
Hosaka, Tetsuya
Sezaki, Hitomi
Kobayashi, Mariko
Kumada, Hiromitsu
INTERVIROLOGY, 2007, 50 (01) : 16 - 23
[30] Influence of end-stage renal disease on long-term survival after major amputation
Meyer, Alexander
Griesbach, Colin
Maudanz, Nils
Lang, Werner
Almasi-Sperling, Veronika
Rother, Ulrich
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2020, 49 (04) : 317 - 322

← 1 2 3 4 5 →